Trial Profile

A randomized, open-label, single-dosing, crossover study to compare the safety and pharmacokinetic characteristics of TuNEX injection 25 mg with those of Enbrel injection 25 mg after subcutaneous injection in healthy male volunteers.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Sep 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

14 Nov 2011 Results published in the Clinical Therapeutics.
26 Aug 2011 Actual initiation date (Mar 2007) added as reported by Korean Clinical Trials Register.
26 Aug 2011 New source identified and integrated (Korean Clinical Trials Register; KCT0000118).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com